摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

meso-[4-(pyridin-2-ylmethoxy)phenyl]dipyrromethene | 1426854-96-7

中文名称
——
中文别名
——
英文名称
meso-[4-(pyridin-2-ylmethoxy)phenyl]dipyrromethene
英文别名
2-pcdpm;2-[[4-[1H-pyrrol-2-yl(pyrrol-2-ylidene)methyl]phenoxy]methyl]pyridine
meso-[4-(pyridin-2-ylmethoxy)phenyl]dipyrromethene化学式
CAS
1426854-96-7
化学式
C21H17N3O
mdl
——
分子量
327.385
InChiKey
WVWCIQFWDSIXNY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    50.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    bis[dichloro(pentamethylcyclopentadienyl)iridium(III)] 、 meso-[4-(pyridin-2-ylmethoxy)phenyl]dipyrromethene三乙胺 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 4.0h, 以55%的产率得到[(η5-C5Me5)IrCl(2-pcdpm)]
    参考文献:
    名称:
    DNA Binding and Anti-Cancer Activity of Redox-Active Heteroleptic Piano-Stool Ru(II), Rh(III), and Ir(III) Complexes Containing 4-(2-Methoxypyridyl)phenyldipyrromethene
    摘要:
    The synthesis of four novel heteroleptic dipyrrinato complexes [(eta(6)-arene)RuCl(2-pcdpm)] (eta(6)-arene = C6H6, 1; C10H14, 2) and [(eta(5)-C5Me5)MCl(2-pcdpm)] (M = Rh, 3; Ir, 4) containing a new chelating ligand 4-(2-methoxypyridyl)-phenyldipyrromethene (2-pcdpm) have been described. The complexes 1-4 have been fully characterized by various physicochemical techniques, namely, elemental analyses, spectral (ESI-MS, IR, H-1, C-13 NMR, UV/vis) and electrochemical studies (cyclic voltammetry (CV) and differential pulse voltammetry (DPV)). Structures of 3 and 4 have been determined crystallographically. In vitro antiproliferative and cytotoxic activity of these complexes has been evaluated by trypan blue exclusion assay, cell morphology, apoptosis, acridine orange/ethidium bromide (AO/EtBr) fluorescence staining, and DNA fragmentation assay in Dalton lymphoma (DL) cell lines. Interaction of 1-4 with calf thymus DNA (CT DNA) has also been supported by absorption titration and electrochemical studies. Our results suggest that in vitro antitumor activity of 1-4 lies in the order 2 > 1 > 4 > 3.
    DOI:
    10.1021/ic302196v
  • 作为产物:
    参考文献:
    名称:
    DNA Binding and Anti-Cancer Activity of Redox-Active Heteroleptic Piano-Stool Ru(II), Rh(III), and Ir(III) Complexes Containing 4-(2-Methoxypyridyl)phenyldipyrromethene
    摘要:
    The synthesis of four novel heteroleptic dipyrrinato complexes [(eta(6)-arene)RuCl(2-pcdpm)] (eta(6)-arene = C6H6, 1; C10H14, 2) and [(eta(5)-C5Me5)MCl(2-pcdpm)] (M = Rh, 3; Ir, 4) containing a new chelating ligand 4-(2-methoxypyridyl)-phenyldipyrromethene (2-pcdpm) have been described. The complexes 1-4 have been fully characterized by various physicochemical techniques, namely, elemental analyses, spectral (ESI-MS, IR, H-1, C-13 NMR, UV/vis) and electrochemical studies (cyclic voltammetry (CV) and differential pulse voltammetry (DPV)). Structures of 3 and 4 have been determined crystallographically. In vitro antiproliferative and cytotoxic activity of these complexes has been evaluated by trypan blue exclusion assay, cell morphology, apoptosis, acridine orange/ethidium bromide (AO/EtBr) fluorescence staining, and DNA fragmentation assay in Dalton lymphoma (DL) cell lines. Interaction of 1-4 with calf thymus DNA (CT DNA) has also been supported by absorption titration and electrochemical studies. Our results suggest that in vitro antitumor activity of 1-4 lies in the order 2 > 1 > 4 > 3.
    DOI:
    10.1021/ic302196v
点击查看最新优质反应信息

文献信息

  • Structural diversity in heteroleptic dipyrrinato copper(II) complexes
    作者:Rakesh Kumar Gupta、Rampal Pandey、Amit Kumar、K.V. Ramanujachary、Samuel E. Lofland、Daya Shankar Pandey
    DOI:10.1016/j.ica.2013.09.044
    日期:2014.1
    Synthesis and characterization of the heteroleptic dipyrrinato complexes [Cu-2(2-pcdpm)(2)(acac)(2)] (1), [Cu-2(2-pcdpm)(2)(hfacac)(2)] (2), [Cu-3(4-OHdpm)(2)(acac)(4)] (3), [Cu-3(4-OHdpm)(2)(hfacac) 4] (4), [Cu-2(3-OHdpm)(acac)(3)] (5), [Cu-2(3-OHdpm)(hfacac)(3)] (6), [Cu(2-OHdpm)(acac)] (7) and [Cu((2)OHdpm)(hfacac)] (8) (acac = acetylacetone; hfacac = hexafluoroacetylacetone; 2-pcdpm = 4-(2-methoxypyridyl) phenyldipyrromethene; 3-pcdpm = 4-(3-methoxypyridyl) phenyldipyrromethene; 4-pcdpm = 4-(4-methoxypyridyl) phenyldipyrromethene; 4-/3-/2-OHdpm = 4-/3-/(2-hydroxyphenyl)dipyrromethene) have been described. The complexes 1-8 have been characterized by elemental analyses, ESI-MS, IR, UV-Vis, EPR and electrochemical (CV and DPV) studies. Electronic absorption spectra of 1-8 clearly suggested that position of the absorption bands depend on the nuclearity and coordination geometry about the copper(II) centres. Structures of 1, 2, 3 and 7 have been determined by X-ray single crystal analyses. The spectral and structural studies revealed that copper(II) in 1 and 2 adopted square pyramidal geometry, whereas in 7 a square planar geometry. On the other hand in trinuclear complex 3 one copper(II) adopted square planar, while other two square pyramidal geometry. In their cyclic voltammo-grams, 1-6 exhibited an irreversible oxidation and two reduction waves whereas 7 and 8 displayed one oxidation and reduction wave. Variable temperature magnetic susceptibility measurements suggested paramagnetic nature of the complexes 1-3. The X-ray photoelectron spectroscopic (XPS) studies indicated that copper(II) centres in complex 3 are present in two different coordination environments. Room temperature EPR studies on 1-8 (g(parallel to) > g(perpendicular to) > 2.003) suggested a typical d(9) copper(II) with unpaired electron lying in a d(x2-y2) orbital. (C) 2013 Elsevier B. V. All rights reserved.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯